Vaccinex, Inc. (VCNX)
NASDAQ: VCNX · Real-Time Price · USD
4.750
+0.040 (0.85%)
Sep 20, 2024, 4:00 PM EDT - Market closed

Vaccinex Revenue

Vaccinex had revenue of $232.00K in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to $356.00K, down -56.85% year-over-year. In the year 2023, Vaccinex had annual revenue of $570.00K with 107.27% growth.

Revenue (ttm)
$356.00K
Revenue Growth
-56.85%
P/S Ratio
14.92
Revenue / Employee
$8,900
Employees
40
Market Cap
8.21M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023570.00K295.00K107.27%
Dec 31, 2022275.00K-625.00K-69.44%
Dec 31, 2021900.00K275.00K44.00%
Dec 31, 2020625.00K102.00K19.50%
Dec 31, 2019523.00K-201.00K-27.76%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pulmatrix 11.39M
Syra Health 7.07M
NeuroMetrix 4.38M
Intelligent Bio Solutions 3.11M
Addex Therapeutics 1.53M
TFF Pharmaceuticals 1.20M
Soligenix 494.62K
Bionomics 451.25K
Revenue Rankings